Disease model incorporation into an artificial immune system (AIS)

Details for Australian Patent Application No. 2007258385 (hide)

Owner VaxDesign Corporation

Inventors Sanchez-Schmitz, Guzman; Higbee, Russell; Rivard, Michael; Fahlenkamp, Heather; Warren, William L.; Mishkin, Eric

Agent Davies Collison Cave

Pub. Number AU-A-2007258385

PCT Pub. Number WO2007/146267

Priority 11/453,003 15.06.06 US

Filing date 12 June 2007

Wipo publication date 21 December 2007

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/146267 Priority application(s): WO2007/146267

23 June 2011 Assignment before Grant

  VaxDesign Corporation The application has been assigned to Sanofi Pasteur VaxDesign Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007258386-Methods for reducing or preventing liquid-liquid phase separation in high concentration protein salutions

2007258383-Static progressive surface region in optical communication with a dynamic optic